OrganiGram Aktie

As of June 2025, the U.S. cannabis industry continues its rapid expansion. Projections estimate the market will reach approximately $45 billion in revenue this year. This growth is fueled by increasing consumer demand, introducing innovative products, and technological advancements in cultivation and production. Despite federal prohibition, 24 states have legalized adult-use cannabis, and 39 states have legalized medical cannabis. However, federal legalization efforts face challenges. In May 2025, the 1st U.S. Circuit Court of Appeals upheld the federal ban on marijuana, rejecting a legal challenge by several Massachusetts cannabis businesses. This decision underscores the ongoing tension between federal law and evolving state cannabis regulations. Additionally, while the Biden administration has proposed reclassifying marijuana to a less restricted category, the outcome remains uncertain, especially under a new administration.» Mehr auf marijuanastocks.com

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the “Board”) to advance Organigram's strategic objectives, including.» Mehr auf businesswire.com

Organigram Global reported record-high revenues for Q2 and improved net income. The company is now selling cannabis beverages in Canada and hemp-derived cannabis beverages in the US. Organigram Global is ramping up its facilities in Canada to meet international demand.» Mehr auf seekingalpha.com